IP Library Granted Patent US 9,408,912
Granted Patent B2
US 9,408,912 · App. 13/877,891 · Granted Aug 9, 2016

Agglomerating magnetic alkoxysilane-coated nanoparticles

Inventors: Norbert Waldöfner (Duisburg, DE); Andreas Jordan (Berlin, DE)
Assignee: MagForce AG
A61K41/0052A61K9/5146H01F1/0054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,912
App. No.
13/877,891
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention relates to a method for producing a suspension of agglomerates of magnetic alkoxysilane-coated metal nanoparticles, wherein an aqueous suspension of magnetic metal nanoparticles is incubated with alkoxysilane, wherein the incubation is carried out essentially in the absence of an organic solvent. The present invention further relates to suspension of agglomerates of magnetic alkoxysilane-coated metal containing nanoparticles obtainable by the method of the present invention and to a composition comprising agglomerates of magnetic alkoxysilane-coated metal nanoparticles, wherein the agglomerates have an average size of 30 to 450 nm, preferably of 50 to 350 nm and especially of 70 to 300 nm as determined by light scattering.

Claims (18)

1. A method for producing a suspension of agglomerates of magnetic alkoxysilane-coated metal nanoparticles, wherein an aqueous suspension of magnetic metal nanoparticles is incubated with alkoxysilane, wherein said incubation is carried out in the absence of added organic solvent, wherein the alkoxysilane is trialkoxysilane and wherein 0.3 to 0.6×10 −3 mol trialkoxlysilane is added per 0.9 mol metal.

2. The method according to claim 1 , wherein the metal nanoparticles comprise iron, iron complex compounds, iron carbonyl compounds or iron salts.

3. The method according to claim 2 , wherein the iron salt is an iron oxide.

4. The method according to the claim 3 , wherein the aqueous suspension of iron oxide nanoparticles is

a) provided by precipitating a solution containing a mixture of iron (III) chloride and iron (II) chloride with sodium hydroxide, or

b) provided by thermal decomposition of an iron salt or an iron complex compound.

5. The method according to claim 1 , wherein the magnetic metal nanoparticles are treated with H 2 O 2 prior to the incubation.

6. The method according to claim 1 , wherein the trialkoxysilane is selected from the group consisting of 3-(2-aminoethylamino)-propyl-trimethoxysilane, 3-aminopropyltriethoxysilane, trimethoxysilylpropyl-diethylenetriamine and N-(6-aminohexyl)-3-aminopropyltrimethoxysilane.

7. The method according to claim 1 , wherein 0.4 to 0.5×10 −3 mol trialkoxysilane is added per 0.9 mol metal.

8. Method according to claim 1 , wherein the incubation is performed at a pH between 2 and 6.

9. Method according to claim 1 , wherein the metal magnetic nanoparticles are disintegrated prior to the incubation with alkoxysilane.

10. Method according to claim 1 , further comprising the step of disintegrating the magnetic nanoparticles after starting the incubation with alkoxysilane.

11. Method according to claim 1 , further comprising the step of removing incompletely coated nanoparticles.

12. Method according to claim 9 , wherein the agglomerates are disintegrated until an average size of 30 to 450 nm as determined by light scattering is achieved.

13. Method according to claim 1 , wherein the suspension of agglomerates is concentrated to a concentration of at least about 2 M as determined by its metal content.

14. The method according to claim 1 , wherein the suspension of agglomerates is concentrated to a concentration of at least about 6 M as determined by its metal content.

15. The method according to claim 3 , wherein the iron salt is magnetite.

16. The method according to claim 3 , wherein the iron salt is maghemite.

Assignments (3)
CHANGE OF NAME Recorded Feb 26, 2026
From: MAGFORCE NT GMBH
To: NANOTHERM THERAPEUTICS GMBH
Reel/Frame 074960/0959 →
SHARE AND ASSET PURCHASE AGREEMENT Recorded Feb 26, 2026
From: MAGFORCE AG
To: MAGFORCE NT GMBH
Reel/Frame 074961/0095 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2013
From: WALDOFNER, NORBERT; JORDAN, ANDREAS
To: MAGFORCE AG
Reel/Frame 030663/0065 →
Continuity (2)
Provisional Application 61522217 · Aug 10, 2011
Related Publication 20140154324A1 · Jun 5, 2014